喜炎平注射液治疗手足口病人群的联合用药方案复杂网络分析

doi:10.19803/j.1672-8629.2022.08.06

中国药物警戒 ›› 2022, Vol. 19 ›› Issue (8): 839-844.
DOI: 10.19803/j.1672-8629.2022.08.06

• 中成药适宜人群用药真实世界研究专栏 • 上一篇下一篇

喜炎平注射液治疗手足口病人群的联合用药方案复杂网络分析

杜莹¹, 王志飞^1#, 谢雁鸣^1*, 王连心¹, 李利寻¹, 刘志帅²

¹中国中医科学院中医临床基础医学研究所,北京 100700;
²中国人民大学统计学院,北京100872

收稿日期:2021-02-18 出版日期:2022-08-15 发布日期:2022-08-15
通讯作者: ^*谢雁鸣,女,研究员·博导,中药上市后再评价和老年病防治。E-mail：ktzu2018@163.com;^#为共同通信作者。
作者简介:杜莹,女,硕士,中医临床评价方法。
基金资助:
国家自然科学基金资助项目（81973982）; 国家重点研发计划（2018YFC1707410）

Complex network analysis of combined regimens of Xiyanping injection in the treatment of hand-foot-mouth disease

DU Ying¹, WANG Zhifei^1#, XIE Yanming^1*, WANG Lianxin¹, LI Lixun¹, LIU Zhishuai²

¹Institute of Basic Clinical Medicine of Traditional Chinese Medicine, China Academy of Chinese Medical Sciences, Beijing 100700, China;
²School of Statistics, Renmin University of China, Beijing 100872, China

Received:2021-02-18 Online:2022-08-15 Published:2022-08-15

摘要/Abstract

摘要： 目的获得喜炎平注射液在真实世界中治疗手足口病人群的联合用药方案。方法收集2006年12月1日至2016年6月30日全国28家三甲医院HIS系统的病例,着重针对喜炎平注射液治疗手足口病的人群进行分析,采用Tabu搜索算法,对真实世界研究中庞大但质量较高的数据进行复杂网络建模。结果共获得19 999名患者联合用药信息数据,构建核心联用西药类别用药子结构群,频次第1位为喜炎平注射液+维生素类,第2位为喜炎平注射液+干扰素类,第3位为喜炎平注射液+免疫增强剂;核心联用中药用类别药频次第1位为喜炎平注射液+清热剂,第2位为喜炎平注射液+开窍剂,第3位为喜炎平注射液+清热解毒剂。结论喜炎平注射液联合用药可用于治疗手足口病轻、重症患者,为临床治疗提供参考。

关键词: 喜炎平注射液, 手足口病, 联合用药, 复杂网络, Tabu 搜索算法, 真实世界

Abstract: Objective To obtain the combined medication schemes of Xiyanping injection in the treatment of hand-foot-mouth disease in the real world. Methods The clinical data on patients with hand-foot-mouth disease treated by Xiyanping injection between December 1, 2006 and June 30, 2016 was collected from 28 large hospitals in China and analyzed with the Tabu search algorithm. Complex network modeling of large but high-quality data in the real-world research was attempted. Results The data on combined medications of a total of 19 999 patients was harvested. Based on the sub structure group of categories of core combinations with western medicine, the most frequently used combination was Xiyanping injection + vitamins, followed by Xiyanping injection + interferons and Xiyanping injection + immune enhancers. The most frequently used core combination with traditional Chinese medicine was Xiyanping injection + antipyretics, followed by Xiyanping injection + formula for resuscitation and Xiyanping injection + antipyretics or antidotes. Conclusion Xiyanping injection is often used in combination with other drugs in the treatment of mild and severe hand-foot-and mouth disease .

Key words: Xiyanping iniection, hand-foot-mouth (HFMD), complex networks, Tabu search algorithms, real world

中图分类号:

R969

杜莹, 王志飞, 谢雁鸣, 王连心, 李利寻, 刘志帅. 喜炎平注射液治疗手足口病人群的联合用药方案复杂网络分析[J]. 中国药物警戒, 2022, 19(8): 839-844.

DU Ying, WANG Zhifei, XIE Yanming, WANG Lianxin, LI Lixun, LIU Zhishuai. Complex network analysis of combined regimens of Xiyanping injection in the treatment of hand-foot-mouth disease[J]. Chinese Journal of Pharmacovigilance, 2022, 19(8): 839-844.

参考文献

[1] BAO LJ, XU FM, LIANG XX.Research progress on epidemiological characteristics and vaccine of hand, foot and mouth disease in China[J]. Advances in Microbiology and Immunology(微生物学免疫学进展), 2020, 48(6): 82-86.
[2] LIU KP, LUO F, MEN GG, et al.Influential factors of nervous system damage in children with severe hand, foot and mouth disease[J].Chinese Journal of Preventive Medicine(中国预防医学杂志), 2020, 21(9): 987-989.
[3] WANG LX, YANG W, XIE YM, et al.Clinical application and safety analysis of 4023 cases of Xiyanping injection in the real world[J]. Journal of Traditional Chinese Medicine(中医杂志), 2014, 55(7): 571-575.
[4] WANG ZF, XIE YM.Analysis of clinical dose application of Xiyanping injection HIS based on real world[J]. China Journal of Chinese Materia Medica(中国中药杂志), 2012, 37(18): 2727-2729.
[5] ZHANG L, HE DG.TCM syndrome differentiation of hand, foot and mouth disease[J]. Chinese Journal of Pediatrics(中医儿科杂志), 2011, 7(4): 36-37.
[6] HE YF.Efficacy of α-1b interferon atomization combined with Xiyanping in the treatment of hand, foot and mouth disease[J].Jiangxi Medical Journal(江西医药), 2019, 54(12): 1627-1628.
[7] ZHUANG Y, XIE BT, WENG SX, et al.Construction and Implementation of his“real world”integrated data warehouse for post-market evaluation of Chinese medicine[J]. China Journal of Chinese Materia Medica(中国中药杂志), 2011, 36(20): 2883-2887.
[8] LIU H, XIE YM, YI DH, et al.Analysis of the characteristics and clinical medication characteristics of Parkinson’s disease patients[J]. China Journal of Chinese Materia Medica(中国中药杂志), 2014, 39(18): 3493-3498.
[9] ZHAO SC, WEI RL, XIE YM, et al.Complex network analysis of 2147 cases of upper respiratory tract infection treated with Qingkailing Injection in the real world[J]. Chinese Journal of Traditional ChineseMedicine(中国中药杂志), 2019, 44(23): 5207-5216.
[10] Guidelines for diagnosis and treatment of hand foot and mouth disease (2018 Edition)[J]. Chinese Journal of Infectious Diseases(中华传染病杂志), 2018, 36(5): 257-263.
[11] CUI J, SI FG.Research progress of clinical application of Xiyanping injection[J]. Huaihai Pharmaceutical(淮海医药), 2018, 39(3): 378-380.
[12] WANG ZF, FAN HW, XIE YM.Real world study of Xiyanping injection combined drug therapy for hand, foot and mouth disease[J].China Journal of Chinese Materia Medica(中国中药杂志), 2016, 41(24): 4510-4515.
[13] WANG Q.Observation on the effect of recombinant human interferon combined with Xiyanping in the treatment of severe hand, foot and mouth disease complicated with viral encephalitis[J]. Exploration of Rational Drug Use in China(中国合理用药探索), 2019,16(12): 92-94.
[14] HU FY, HU LT, LI Y, et al.Recombinant human interferon α- Clinical observation of 2B atomization combined with ribavirin and Xiyanping intravenous drip in the treatment of children’s hand, foot and mouth disease[J]. Chinese Medical Innovation(中国医学创新), 2019, 16(24): 24-27.
[15] ZOU GF.The clinical effect of Xiyanping combined with immunoglobulin in the treatment of severe hand, foot and mouth disease in children[J]. Journal of Clinical Rational Drug Use(临床合理用药杂志), 2018, 11(11): 75-76.
[16] Clinical technical guidelines for the treatment of hand, foot and mouth disease with traditional Chinese medicine (2012 Edition)[J]. Zhejiang Journal of Integrated Traditional Chinese and Western Medicine(浙江中西医结合杂志), 2012, 22(9): 750.
[17] LIU L, WANG YP, JING WC, et al.Discussion on the etiology and pathogenesis of hand, foot and mouth disease in children in cold areas based on the theory of febrile disease[J]. Chinese Traditional Medicine Emergency(中国中医急症), 2019, 28(6): 1036-1038, 1041.
[18] WAN L.Qingre xiepi powder combined with traditional Chinese medicine enema in the treatment of 60 cases of common hand, foot and mouth disease[J]. Shaanxi Traditional Chinese Medicine(陕西中医), 2015, 36(8): 1033-1035.

喜炎平注射液治疗手足口病人群的联合用药方案复杂网络分析

Complex network analysis of combined regimens of Xiyanping injection in the treatment of hand-foot-mouth disease

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

[1]	史卜文, 李利寻, 谢雁鸣, 王志飞, 王淇. 真实世界喜炎平注射液治疗3846例细菌性肠道感染患者临床用药特征分析[J]. 中国药物警戒, 2023, 20(9): 1017-1021.
[2]	严亦舒, 赵岩, 卢天公, 孙震晓. 大黄素-8-O-β-D-葡萄糖苷联合紫杉醇抑制人乳腺癌细胞活力及侵袭转移的研究[J]. 中国药物警戒, 2023, 20(7): 728-734.
[3]	王淑伟, 殷进军, 王冰, 宋彩萍, 杨福俊. 阿昔替尼片联合特瑞普利单抗治疗晚期肾癌致视网膜中央动脉阻塞1例分析[J]. 中国药物警戒, 2023, 20(7): 825-828.
[4]	罗琼, 李盟, 李光耀, 何彦春, 周祖山, 孙鑫, 刘成海. 635例类风湿性关节炎患者应用雷公藤制剂所致肝损伤的中医证候及联合用药特点[J]. 中国药物警戒, 2023, 20(5): 500-504.
[5]	赵燕, 刘文博, 赵一飞, 李栋, 郑立佳, 宋雅娜, 赵玉娟, 董放. 患者登记研究应用于医疗器械监管科学的实践研究与思考[J]. 中国药物警戒, 2023, 20(4): 423-427.
[6]	杜莹, 谢雁鸣, 王连心, 耿洪娇, 李向杰. 真实世界连花清瘟胶囊（颗粒）适应证人群临床特征及联合用药分析[J]. 中国药物警戒, 2023, 20(3): 296-300.
[7]	杜莹, 赵晓晓, 谢雁鸣, 余小康. 基于真实世界使用榄香烯乳状注射液影响肝功能的倾向性评分分析[J]. 中国药物警戒, 2023, 20(2): 191-195.
[8]	王嘉熙, 郭代红, 张博, 李伯妍, 郭海丽. 116097例氟比洛芬酯用药人群的急性肾损伤自动监测研究及危险因素分析[J]. 中国药物警戒, 2023, 20(2): 201-205.
[9]	姚鑫, 葛秋格, 李亚敏, 王一帆, 李媛媛, 刘志强. 2018~2022年某院新型抗肿瘤药物消化系统不良反应分析[J]. 中国药物警戒, 2023, 20(11): 1273-1278.
[10]	吴昀效, 于玥琳, 王胜锋, 孙凤, 孟若谷, 詹思延. 真实世界数据在疫苗上市后安全性主动监测中适用性评价分析[J]. 中国药物警戒, 2023, 20(10): 1081-1089.
[11]	孙静, 赵荣华, 包蕾, 郭姗姗, 耿子涵, 李舒冉, 徐英莉, 崔晓兰. 疏风解毒胶囊联合左氧氟沙星治疗多重耐药铜绿假单胞菌感染性小鼠肺炎的作用研究[J]. 中国药物警戒, 2023, 20(1): 52-56.
[12]	王辉强, 颜海燕, 李兴琼, 杨杰, 李玉环. 盐酸石蒜碱硫酯体内抗柯萨奇病毒A16的药效研究[J]. 中国药物警戒, 2023, 20(1): 79-84.
[13]	苏鑫鑫, 赵晓晓, 谢雁鸣. 榄香烯乳注射液治疗肝癌患者的真实世界联合用药分析[J]. 中国药物警戒, 2022, 19(9): 929-934.
[14]	黄艳丽, 谢雁鸣, 王连心, 孙粼希, 刘峘, 庄鋆妮. 真实世界老年患者使用刺五加注射液的临床分析[J]. 中国药物警戒, 2022, 19(9): 935-939.
[15]	赵晓晓, 谢雁鸣, 王连心. 真实世界榄香烯乳状注射液治疗肺癌临床应用特征研究[J]. 中国药物警戒, 2022, 19(9): 940-946.